» Articles » PMID: 3349520

Injection of Mitochondria into Human Cells Leads to a Rapid Replacement of the Endogenous Mitochondrial DNA

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1988 Mar 25
PMID 3349520
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Isolated human mitochondria containing a mitochondrial DNA (mtDNA) coded chloramphenicol resistance marker were injected into cells from two different human sensitive cell lines, 143BTK- and HT1080-6TG, which had been partially depleted of their mtDNA by ethidium bromide treatment. On the basis of the available evidence concerning the tolerance of introduced volumes into mammalian cells, it is estimated that, on the average, less than one mitochondrion was introduced into each cell. Under selective conditions, the mitochondria became established in the recipient cells with a frequency greater than 2-3 x 10(-3). An analysis of multiple mtDNA and nuclear DNA polymorphisms revealed a rapid replacement of the resident mtDNA by the exogenous mtDNA. Six to ten weeks after microinjection, this replacement was complete in all but one of the HT1080-6TG transformants, and nearly complete in the majority of the 143BTK- transformants. The quantitative behavior of the mtDNA of the transformants at very early stages of selection strongly suggests that intracellular mtDNA selection played a crucial role in this replacement, with significant implications for mitochondrial genetics.

Citing Articles

Engineered mitochondria in diseases: mechanisms, strategies, and applications.

Li M, Wu L, Si H, Wu Y, Liu Y, Zeng Y Signal Transduct Target Ther. 2025; 10(1):71.

PMID: 40025039 PMC: 11873319. DOI: 10.1038/s41392-024-02081-y.


Recommendations for mitochondria transfer and transplantation nomenclature and characterization.

Brestoff J, Singh K, Aquilano K, Becker L, Berridge M, Boilard E Nat Metab. 2025; 7(1):53-67.

PMID: 39820558 DOI: 10.1038/s42255-024-01200-x.


An Engineered Hierarchical Hydrogel with Immune Responsiveness and Targeted Mitochondrial Transfer to Augmented Bone Regeneration.

Cai W, Mao S, Wang Y, Gao B, Zhao J, Li Y Adv Sci (Weinh). 2024; 11(42):e2406287.

PMID: 39258577 PMC: 11558138. DOI: 10.1002/advs.202406287.


Aberrant ER-mitochondria communication is a common pathomechanism in mitochondrial disease.

Morcillo P, Kabra K, Velasco K, Cordero H, Jennings S, Yun T Cell Death Dis. 2024; 15(6):405.

PMID: 38858390 PMC: 11164949. DOI: 10.1038/s41419-024-06781-9.


Mitochondrial transfer - a novel promising approach for the treatment of metabolic diseases.

Chen R, Chen J Front Endocrinol (Lausanne). 2024; 14:1346441.

PMID: 38313834 PMC: 10837849. DOI: 10.3389/fendo.2023.1346441.